These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19747783)

  • 1. NTCP modeling of subacute/late laryngeal edema scored by fiberoptic examination.
    Rancati T; Fiorino C; Sanguineti G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):915-23. PubMed ID: 19747783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
    Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric predictors of laryngeal edema.
    Sanguineti G; Adapala P; Endres EJ; Brack C; Fiorino C; Sormani MP; Parker B
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):741-9. PubMed ID: 17398024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy.
    Bakhshandeh M; Hashemi B; Mahdavi SR; Nikoofar A; Vasheghani M; Kazemnejad A
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):514-21. PubMed ID: 22583606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
    Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
    Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models.
    Söhn M; Yan D; Liang J; Meldolesi E; Vargas C; Alber M
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1066-73. PubMed ID: 17258870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal tissue complication probability models for severe acute radiological lung injury after radiotherapy for lung cancer.
    Avanzo M; Trovo M; Furlan C; Barresi L; Linda A; Stancanello J; Andreon L; Minatel E; Bazzocchi M; Trovo MG; Capra E
    Phys Med; 2015 Feb; 31(1):1-8. PubMed ID: 25455442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
    Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
    Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.
    Scrimger RA; Stavrev P; Parliament MB; Field C; Thompson H; Stavreva N; Fallone BG
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):178-85. PubMed ID: 15337554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.
    Seppenwoolde Y; Lebesque JV; de Jaeger K; Belderbos JS; Boersma LJ; Schilstra C; Henning GT; Hayman JA; Martel MK; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):724-35. PubMed ID: 12573760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic laryngeal edema as a late reaction to radiochemotherapy].
    Dietz A; Rudat V; Nollert J; Helbig M; Vanselow B; Weidauer H
    HNO; 1998 Aug; 46(8):731-8. PubMed ID: 9773329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery.
    Daly ME; Luxton G; Choi CY; Gibbs IC; Chang SD; Adler JR; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2025-32. PubMed ID: 21531516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of arytenoid edema following radiotherapy of laryngeal carcinoma with respect to residual and recurrent tumour.
    Ichimura K; Sugasawa M; Nibu K; Takasago E; Hasezawa K
    Auris Nasus Larynx; 1997 Oct; 24(4):391-7. PubMed ID: 9352832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
    Tucker SL; Dong L; Cheung R; Johnson J; Mohan R; Huang EH; Liu HH; Thames HD; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1589-601. PubMed ID: 15590191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability Analysis.
    Jakobi A; Bandurska-Luque A; Stützer K; Haase R; Löck S; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1165-1174. PubMed ID: 26194685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical comparative study of dose-volume and equivalent uniform dose based predictions in post radiotherapy acute complications.
    Boulé TP; Gallardo Fuentes MI; Roselló JV; Arrans Lara R; Torrecilla JL; Plaza AL
    Acta Oncol; 2009; 48(7):1044-53. PubMed ID: 19575313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
    Bentzen SM; Saunders MI; Dische S
    Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of image-guided radiotherapy to reduce laryngeal edema following treatment for non-laryngeal and non-hypopharyngeal head and neck cancers.
    Nguyen NP; Abraham D; Desai A; Betz M; Davis R; Sroka T; Chi A; Gelumbauskas S; Ceizyk M; Smith-Raymond L; Stevie M; Jang S; Hamilton R; Vinh-Hung V
    Oral Oncol; 2011 Sep; 47(9):900-4. PubMed ID: 21724448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
    Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
    Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
    Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
    Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.